D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 48 Citations 11,623 184 World Ranking 11083 National Ranking 103

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

His primary areas of investigation include Leukemia, Cancer research, Genetics, Mutation and Internal medicine. His Leukemia research is under the purview of Immunology. His Cancer research study integrates concerns from other disciplines, such as Epigenetics, Regulation of gene expression, microRNA and GATA1.

His studies in Mutation integrate themes in fields like Embryonic stem cell, Xenopus, Anatomy, Molecular biology and Acute lymphocytic leukemia. His research integrates issues of Oncology and Locus in his study of Internal medicine. Shai Izraeli interconnects Chromosome breakage and Gene rearrangement in the investigation of issues within Acute leukemia.

His most cited work include:

  • Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration (410 citations)
  • The MLL recombinome of acute leukemias in 2013 (344 citations)
  • New insights to the MLL recombinome of acute leukemias (327 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Cancer research, Leukemia, Immunology, Internal medicine and Genetics. His studies deal with areas such as Haematopoiesis, STAT5, Acute lymphocytic leukemia and B cell as well as Cancer research. His specific area of interest is Leukemia, where Shai Izraeli studies Acute leukemia.

His Immunology study combines topics in areas such as Down syndrome and Somatic cell. His Internal medicine study incorporates themes from Gastroenterology and Oncology. His Gene study combines topics from a wide range of disciplines, such as Molecular biology and Cell biology.

He most often published in these fields:

  • Cancer research (49.31%)
  • Leukemia (44.10%)
  • Immunology (30.90%)

What were the highlights of his more recent work (between 2015-2021)?

  • Leukemia (44.10%)
  • Cancer research (49.31%)
  • Internal medicine (19.10%)

In recent papers he was focusing on the following fields of study:

Shai Izraeli mostly deals with Leukemia, Cancer research, Internal medicine, Haematopoiesis and Immunology. He is studying Acute leukemia, which is a component of Leukemia. His Cancer research research is multidisciplinary, incorporating perspectives in Cancer cell, B cell, STAT5, Stem cell and Kinase.

Shai Izraeli combines subjects such as Molecular genetics and Oncology with his study of Internal medicine. His Haematopoiesis research incorporates elements of Progenitor cell and Germline mutation. His study in Immunology is interdisciplinary in nature, drawing from both Down syndrome and Somatic cell.

Between 2015 and 2021, his most popular works were:

  • The MLL recombinome of acute leukemias in 2017 (231 citations)
  • The MLL recombinome of acute leukemias in 2017 (231 citations)
  • The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice (164 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Leukemia, Cancer research, Genetics, Immunology and Mutation are his primary areas of study. He is interested in Acute leukemia, which is a field of Leukemia. The various areas that Shai Izraeli examines in his Cancer research study include Cancer cell, Cancer genome and Gene mutation.

His Genetics research is multidisciplinary, relying on both Computational biology and Tumor cells. The study incorporates disciplines such as Down syndrome, Disease and Toxicity in addition to Immunology. His research in the fields of Missense mutation overlaps with other disciplines such as Glucosamine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

Ching Hon Pui;Jun J. Yang;Stephen P. Hunger;Rob Pieters.
Journal of Clinical Oncology (2015)

571 Citations

The MLL recombinome of acute leukemias in 2013

C. Meyer;J. Hofmann;T. Burmeister;D. Gröger.
Leukemia (2013)

461 Citations

Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma

Danit Lebanony;Hila Benjamin;Shlomit Gilad;Meital Ezagouri.
Journal of Clinical Oncology (2009)

445 Citations

New insights to the MLL recombinome of acute leukemias

C. Meyer;E. Kowarz;J. Hofmann;A. Renneville.
Leukemia (2009)

441 Citations

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

Dani Bercovich;Ithamar Ganmore;Linda M. Scott;Gilad Wainreb.
The Lancet (2008)

364 Citations

Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias

Chen Shochat;Noa Tal;Noa Tal;Obul R. Bandapalli;Obul R. Bandapalli;Chiara Palmi.
Journal of Experimental Medicine (2011)

328 Citations

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.

Liat Rainis;Dan Bercovich;Sabine Strehl;Andrea Teigler-Schlegel.
Blood (2003)

296 Citations

The landscape of somatic mutations in Down syndrome-related myeloid disorders

Kenichi Yoshida;Tsutomu Toki;Yusuke Okuno;Rika Kanezaki.
Nature Genetics (2013)

291 Citations

The MLL recombinome of acute leukemias in 2017

C Meyer;T Burmeister;D Gröger;G Tsaur.
Leukemia (2018)

289 Citations

Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol.

Gunnar Cario;Martin Zimmermann;Renja Romey;Stefan Gesk.
Blood (2010)

268 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Shai Izraeli

Ching-Hon Pui

Ching-Hon Pui

St. Jude Children's Research Hospital

Publications: 85

Charles G. Mullighan

Charles G. Mullighan

St. Jude Children's Research Hospital

Publications: 79

Stephen P. Hunger

Stephen P. Hunger

University of Pennsylvania

Publications: 79

Rolf Marschalek

Rolf Marschalek

Goethe University Frankfurt

Publications: 79

Mignon L. Loh

Mignon L. Loh

University of California, San Francisco

Publications: 60

Christine J. Harrison

Christine J. Harrison

Newcastle University

Publications: 59

Martin Schrappe

Martin Schrappe

Kiel University

Publications: 53

Kjeld Schmiegelow

Kjeld Schmiegelow

University of Copenhagen

Publications: 48

Rob Pieters

Rob Pieters

Boston Children's Hospital

Publications: 46

Meenakshi Devidas

Meenakshi Devidas

St. Jude Children's Research Hospital

Publications: 45

William L. Carroll

William L. Carroll

New York University

Publications: 44

Seishi Ogawa

Seishi Ogawa

Kyoto University

Publications: 38

Giuseppe Basso

Giuseppe Basso

University of Padua

Publications: 34

Andrea Biondi

Andrea Biondi

University of Milano-Bicocca

Publications: 32

James R. Downing

James R. Downing

St. Jude Children's Research Hospital

Publications: 32

Dirk Reinhardt

Dirk Reinhardt

University of Duisburg-Essen

Publications: 31

Something went wrong. Please try again later.